RAC Racura Oncology LTD
Pharmaceuticals, Biotechnology & Life Sciences
Next annual general meeting
Monday 23 November 2026
New South Wales · Announced
The company has announced this date. The notice of meeting, with the agenda, is due at least 28 days before.
Last AGM voting results
Results of the AGM held Monday 24 November 2025.
| # | Resolution | For | Against | Result |
|---|---|---|---|---|
| 1 | ADOPTION OF REMUNERATION REPORT | 99.59% | 0.41% | carried |
| 2 | ELECTION OF DIRECTOR – DR MEGAN BALDWIN | 92.36% | 7.64% | carried |
| 3 | RE-ELECTION OF DIRECTOR – DR PETER SMITH | 99.95% | 0.05% | carried |
| 4 | ISSUE OF INCENTIVE OPTIONS TO DR MEGAN BALDWIN | 88.57% | 11.43% | carried |
| 5 | ISSUE OF INCENTIVE OPTIONS TO DR SERGE SCROFANI | 99.81% | 0.19% | carried |
| 6 | ISSUE OF INCENTIVE OPTIONS TO DR PETER SMITH | 99.81% | 0.19% | carried |
| 7 | ISSUE OF OPTIONS IN LIEU OF BONUS ENTITLEMENTS – DR PETER SMITH | 99.83% | 0.17% | carried |
| 8 | ISSUE OF OPTIONS IN LIEU OF BONUS ENTITLEMENTS – DR DANIEL TILLETT | 99.86% | 0.14% | carried |
| 9 | REPLACEMENT OF CONSTITUTION | 99.16% | 0.84% | carried |
| 10 | CHANGE OF COMPANY NAME | 96.50% | 3.50% | carried |